Search research articles
Contact Us
Filters
Showing results (101-110 of 197) with videos related to
Page
of 20
Sort By:
The Annals of Pharmacotherapy
|
March 18, 2003
Branded versus generic clozapine for treatment of schizophrenia
Eugene H Makela, William D Cutlip, James M Stevenson, et al.
Orphanet Journal of Rare Diseases
|
January 23, 2019
Tracking sex-dependent differences in a mouse model of CLN6-Batten disease
McKayla J Poppens, Jacob T Cain, Tyler B Johnson, et al.
Neurobiology of Disease
|
January 18, 2006
Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons
Jill M Weimer, Andrew W Custer, Jared W Benedict, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Development of AITC-induced dermal blood flow as a translational in vivo biomarker of TRPA1 activity in human and rodent skin
Victory Joseph, Xiaoying Yang, Simon S Gao, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 23, 2022
Correction to: The effects of SmartCare© on neuro‑oncology family caregivers' distress: a randomized controlled trial
Florien W Boele, Jason M Weimer, Anna L Marsland, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Toxicology and Applied Pharmacology
|
March 15, 2012
Potential hazards to embryo implantation: A human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals
L Fischer, W R Deppert, D Pfeifer, et al.
Journal of Neurodevelopmental Disorders
|
May 7, 2011
Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia
Sheryl S Moy, H Troy Ghashghaei, Randal J Nonneman, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
Journal of Alzheimer'S Disease : JAD
|
November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
Nicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 197) with videos related to
Sort By:
Page
of 20
The Annals of Pharmacotherapy
|
March 18, 2003
Branded versus generic clozapine for treatment of schizophrenia
Eugene H Makela, William D Cutlip, James M Stevenson, et al.
Orphanet Journal of Rare Diseases
|
January 23, 2019
Tracking sex-dependent differences in a mouse model of CLN6-Batten disease
McKayla J Poppens, Jacob T Cain, Tyler B Johnson, et al.
Neurobiology of Disease
|
January 18, 2006
Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons
Jill M Weimer, Andrew W Custer, Jared W Benedict, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Development of AITC-induced dermal blood flow as a translational in vivo biomarker of TRPA1 activity in human and rodent skin
Victory Joseph, Xiaoying Yang, Simon S Gao, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 23, 2022
Correction to: The effects of SmartCare© on neuro‑oncology family caregivers' distress: a randomized controlled trial
Florien W Boele, Jason M Weimer, Anna L Marsland, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Toxicology and Applied Pharmacology
|
March 15, 2012
Potential hazards to embryo implantation: A human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals
L Fischer, W R Deppert, D Pfeifer, et al.
Journal of Neurodevelopmental Disorders
|
May 7, 2011
Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia
Sheryl S Moy, H Troy Ghashghaei, Randal J Nonneman, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
Journal of Alzheimer'S Disease : JAD
|
November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
Nicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
Page
of 20